GADD45G and central nervous system cancer: We plan to establish a tissue microarray (TMA) resource based on clinical glioma samples and conduct qPCR or protein-level analyses to assess associations between GADD45G expression and tumor grade, subtype, and prognosis, providing stronger evidence for its clinical utility.